Clinical trial
Single-Blind, Controlled Safety and Immunogenicity Study of Recombinant MVA…
NCT00390078 · Bavarian Nordic, Industry · Completed
Key facts
| NCT number | NCT00390078 |
|---|---|
| Title | Single-Blind, Controlled Safety and Immunogenicity Study of Recombinant MVA Virus to Treat HIV Infection |
| Official title | Single-Blind, Randomized, Controlled, Phase I/II Vaccination Study on Safety and Immunogenicity of a Recombinant MVA-HIV Polytope Vaccine (MVA-mBN32) in HIV-1 Infected Patients With CD4 Counts > 250/µl |
| Lead sponsor | Bavarian Nordic, Industry |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Biological |
| Interventions | MVA-mBN32, IMVAMUNE |
| Enrollment | 30 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Jan 1, 2009 |
| First posted | Oct 19, 2006 |
| Last update posted | Jul 10, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: